Quote | Organon & Co. (NYSE:OGN)
Last: | $21.35 |
---|---|
Change Percent: | -1.19% |
Open: | $21.19 |
Close: | $21.35 |
High: | $21.56 |
Low: | $21.135 |
Volume: | 2,141,346 |
Last Trade Date Time: | 05/14/2024 03:00:00 am |
News | Organon & Co. (NYSE:OGN)
2024-05-11 06:58:33 ET Summary Organon, Pfizer, and Bristol Myers all offer yields above 5% and can compete with most Treasuries, but only Organon is up YTD. Spinoffs often struggle in their initial years, but Organon's partial reversal of its decline since Merck's castoff h...
2024-05-09 08:15:00 ET Summary Teva Pharmaceutical stock has been trending higher since October 2023, closing at nearly $16.00. The company reported strong first-quarter results, with increased revenue and growth in key metrics. Teva has a positive business outlook for 2024, w...
Message Board Posts | Organon & Co. (NYSE:OGN)
Subject | By | Source | When |
---|---|---|---|
Looks good. | LordDarley | investorshub | 06/07/2021 3:50:57 PM |
Barrons bullish on$ OGN: | DewDiligence | investorshub | 06/05/2021 6:40:26 PM |
OGN spin-off from $MRK begins trading today: | DewDiligence | investorshub | 06/03/2021 4:14:49 PM |
News, Short Squeeze, Breakout and More Instantly...
Organon & Co. Company Name:
OGN Stock Symbol:
NYSE Market:
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have hig...
Organon (NYSE: OGN) (“Organon”), a global healthcare company with a focus on women’s health, announced today that it, together with Organon Foreign Debt Co-Issuer B.V., a direct wholly-owned subsidiary of Organon, as co-issuer (the “Co-Issuer” and, together with...
Organon (NYSE: OGN) (“Organon”), a global healthcare company with a focus on women’s health, announced today that it, together with Organon Foreign Debt Co-Issuer B.V., a direct wholly-owned subsidiary of Organon, as co-issuer (the “Co-Issuer” and, together with...